Table.
Summarized phenotypic and the main changes in the RAS observed in some animal models of deficiency or overexpression of ACE2 and Mas.
Strategy | Strain | Changes in RAS | Phenotype | Reference |
---|---|---|---|---|
ACE2 overexpression in smooth muscle cells | SHRSP | ↑aortic ACE2 activity | Improved endothelial function | Rentzsch et al19 |
↑Ang-(1-7) plasma/aorta | ||||
↑Ang-(1-7)/Ang II | ||||
Lentiviral ACE2 gene transfer in hearts | SHR | ↑cardiac ACE2 mRNA | BP independent cardioprotection | Diez-Freire et al16 |
↑cardiac ACE2 activity | ||||
ACE2 overexpression in hearts | FVB/NTac | ↑serum ACE2 activity | Cardiac rhythm disturbances and sudden death | Donoghue et al11 |
↑cardiac ACE2 expression | ||||
Adenoviral ACE2 gene transfer in hearts | SHRSP | ↑cardiac ACE2 activity | Severe cardiac fibrosis | Masson et al22 |
↑Ang-(1-7) expression | ||||
↓ACE activity | ||||
ACE2 knockout | Mixed background | ↑cardiac/plasma/renal Ang II | ↓BP and impaired systolic function | Crackower et al8 |
ACE2 knockout | Mixed background | No basal changes | Variable | Gurley et al12 |
ACE2 knockout | Mixed background | No basal changes | No basal changes | Yamamoto et al61 |
Mas knockout | C57BL/6 | ↓Ang-(1-7) binding in cardiac myocytes | Impaired heart function and cardiac fibrosis | Santos et al13 |
Mas knockout | C57BL/6 | Not determined | ↑sympathetic tonus | Walther et al62 |
Mas knockout | C57BL/6 | Not determined | Impaired Ang-(1-7)-mediated aortic relaxation | Peiró et al63 |
Mas knockout | FVB/N | Not determined | ↑BP, impaired endothelial function and ↓NO and eNOS | Xu et al64 |